S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:STIM

Neuronetics News Headlines

$4.12
-0.19 (-4.41%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$4.07
$4.35
50-Day Range
$4.00
$7.08
52-Week Range
$3.94
$22.43
Volume
107,201 shs
Average Volume
469,725 shs
Market Capitalization
$108.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.31

Media Mentions By Week



Neuronetics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

STIM
News Sentiment

0.58

0.26

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

STIM Articles
This Week

10

4

STIM Articles
Average Week

Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.

Neuronetics (NASDAQ:STIM) News Headlines Today

SourceHeadline
MarketBeat logoInsider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Purchases 15,000 Shares of Stock
americanbankingnews.com - November 24 at 5:30 PM
benzinga.com logoNeuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference - Benzinga - Benzinga
benzinga.com - November 23 at 5:08 AM
MarketBeat logoNeuronetics, Inc. (NASDAQ:STIM) Receives Consensus Recommendation of "Hold" from Analysts
americanbankingnews.com - November 23 at 3:28 AM
globenewswire.com logoNeuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference - GlobeNewswire
globenewswire.com - November 22 at 5:39 PM
nasdaq.com logoHow Much Of Neuronetics, Inc. (NASDAQ:STIM) Do Institutions Own? - Nasdaq
nasdaq.com - November 22 at 5:39 PM
finance.yahoo.com logoNeuronetics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
finance.yahoo.com - November 22 at 5:38 PM
MarketBeat logoNeuronetics, Inc. (NASDAQ:STIM) Short Interest Down 18.4% in October
americanbankingnews.com - November 21 at 12:22 PM
MarketBeat logoContrasting NeuroPace (NASDAQ:NPCE) and Neuronetics (NASDAQ:STIM)
americanbankingnews.com - November 20 at 5:11 AM
MarketBeat logoNeuronetics (NASDAQ:STIM) & NeuroPace (NASDAQ:NPCE) Head to Head Contrast
americanbankingnews.com - November 20 at 5:11 AM
MarketBeat logoNeuronetics, Inc. (NASDAQ:STIM) Director Sells $41,324.10 in Stock
americanbankingnews.com - November 16 at 8:22 PM
bizjournals.com logoLab Notes: Imvax presents new data on lead drug candidate; Neuronetics forms new partnership - Philadelphia Business Journal
bizjournals.com - November 12 at 6:02 PM
MarketBeat logoBrokers Set Expectations for Neuronetics, Inc.'s FY2021 Earnings (NASDAQ:STIM)
americanbankingnews.com - November 12 at 7:32 AM
MarketBeat logoNeuronetics, Inc. to Post FY2021 Earnings of ($1.21) Per Share, Piper Sandler Forecasts (NASDAQ:STIM)
americanbankingnews.com - November 12 at 7:32 AM
streetinsider.com logoIMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS - StreetInsider.com
streetinsider.com - November 12 at 1:32 AM
MarketBeat logoNeuronetics, Inc. (NASDAQ:STIM) to Post Q1 2023 Earnings of ($0.33) Per Share, William Blair Forecasts
americanbankingnews.com - November 11 at 8:14 AM
MarketBeat logoNeuronetics (NASDAQ:STIM) Issues Quarterly Earnings Results
americanbankingnews.com - November 10 at 9:40 PM
fool.com logoNeuronetics, Inc. (STIM) Q3 2021 Earnings Call Transcript - Motley Fool
fool.com - November 10 at 1:23 AM
streetinsider.com logoNeuronetics and River Region Psychiatry Announce Exclusive Partnership - StreetInsider.com
streetinsider.com - November 9 at 8:22 PM
nasdaq.com logoNeuronetics, Inc. (STIM) Q3 2021 Earnings Call Transcript - Nasdaq
nasdaq.com - November 9 at 8:22 PM
finance.yahoo.com logoNeuronetics Reports Third Quarter 2021 Financial and Operating Results - Yahoo Finance
finance.yahoo.com - November 9 at 10:21 AM
seekingalpha.com logoNeuronetics and River Region Psychiatry sign exclusive partnership agreement - Seeking Alpha
seekingalpha.com - November 8 at 1:57 PM
finance.yahoo.com logoNeuronetics and River Region Psychiatry Announce Exclusive Partnership
finance.yahoo.com - November 8 at 1:57 PM
finance.yahoo.com logoNeuronetics Celebrates 235,000 Treatment Milestone for Success TMS - Yahoo Finance
finance.yahoo.com - October 26 at 3:40 PM
globenewswire.com logoNeuronetics Celebrates 235000 Treatment Milestone for Success TMS - GlobeNewswire
globenewswire.com - October 26 at 9:56 AM
finance.yahoo.com logoNeuronetics to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call
finance.yahoo.com - October 26 at 9:56 AM
finance.yahoo.com logoNeuronetics Celebrates 235,000 Treatment Milestone for Success TMS
finance.yahoo.com - October 26 at 9:56 AM
finance.yahoo.com logoCORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021 - Yahoo Finance
finance.yahoo.com - October 20 at 12:27 AM
globenewswire.com logoCORRECTION - Neuronetics Announces Preliminary Revenue for - GlobeNewswire
globenewswire.com - October 20 at 12:27 AM
finance.yahoo.com logoCORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021
finance.yahoo.com - October 20 at 12:27 AM
globenewswire.com logoNeuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health - GlobeNewswire
globenewswire.com - October 19 at 9:05 AM
finance.yahoo.com logoNeuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
finance.yahoo.com - October 19 at 9:05 AM
businesswire.com logoThe Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors - Business Wire
businesswire.com - October 14 at 8:36 PM
seekingalpha.com logoNeuronetics' dive continues as William Blair downgrades on estimated revenue miss - Seeking Alpha
seekingalpha.com - October 14 at 3:36 PM
finance.yahoo.com logoIs Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?
finance.yahoo.com - October 14 at 3:36 PM
finance.yahoo.com logoMid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge - Yahoo Finance
finance.yahoo.com - October 13 at 6:34 PM
finance.yahoo.com logoNeuronetics Cuts Q3 Revenue Guidance; Shares Tank 27% Pre-Market - Yahoo Finance
finance.yahoo.com - October 13 at 6:34 PM
finance.yahoo.com logoMid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge
finance.yahoo.com - October 13 at 6:34 PM
seekingalpha.com logoHot Stocks: BLK earnings; PLUG partnership; bullish call on JSPR; STIM warning; PYCR secondary offering - Seeking Alpha
seekingalpha.com - October 13 at 1:10 PM
seekingalpha.com logoJasper Therapeutics, Clarus Therapeutics leads healthcare gainers; NeuroOne Medical Technologies, Neuronetics among major losers - Seeking Alpha
seekingalpha.com - October 13 at 1:10 PM
benzinga.com logoMid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge - Benzinga
benzinga.com - October 13 at 1:10 PM
marketwatch.com logoNeuronetics Down 22% After Guidance Cut - MarketWatch
marketwatch.com - October 13 at 1:10 PM
marketwatch.com logoNeuronetics Shares Down After Guidance Cut - MarketWatch
marketwatch.com - October 13 at 1:10 PM
finance.yahoo.com logoNeuronetics Cuts Q3 Revenue Guidance; Shares Tank 27% Pre-Market
finance.yahoo.com - October 13 at 1:10 PM
benzinga.com logo20 Stocks Moving in Wednesday's Pre-Market Session - Benzinga
benzinga.com - October 13 at 7:49 AM
globenewswire.com logoNeuronetics Announces Preliminary Revenue for Third Quarter 2021 - GlobeNewswire
globenewswire.com - October 12 at 5:53 PM
finance.yahoo.com logoNeuronetics Announces Preliminary Revenue for Third Quarter 2021
finance.yahoo.com - October 12 at 5:53 PM
globenewswire.com logoNeuronetics Announces Commercial Agreement with Success TMS - GlobeNewswire
globenewswire.com - October 6 at 12:53 PM
marketwatch.com logoNeuronetics in Commercial Agreement With Success TMS - MarketWatch
marketwatch.com - October 6 at 12:53 PM
finance.yahoo.com logoNeuronetics Announces Commercial Agreement with Success TMS
finance.yahoo.com - October 6 at 12:53 PM
finance.yahoo.com logoNeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
finance.yahoo.com - October 4 at 9:41 AM
Get Neuronetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.